Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
n-Cyclopentylcyclohexanamine → [5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | n-Cyclopentylcyclohexanamine | HCID 219797 | — |
| 반응물 | Ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetate | HCID 351912 | — |
| 반응물 | [5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid ethyl ester | HCID 66872747 | — |
| 생성물 | [5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid | HCID 57883528 | — |
반응 단계
[5-(3-Cyclohexyl-3-cyclopentyl-ureido)-[1,3,4]thiadiazol-2-ylsulfanyl]-acetic acid ethyl ester prepared as described in general procedures (A) and (B) using cyclohexyl-cyclopentyl-amine and ethyl-2-[5-amino-1,3,4-thiadiazol-2-yl-thio]acetate. Hydrolysis using general procedure (F) gave the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08263634B2 |
| 출처 데이터셋 | uspto-grants-2012_09 |
| ORD ID | ord-4f7836a80b0149b98dd664094bc05f87 |
| 출처 메모 | uspto-grants-2012_09 |